Información del producto
Methyl 4-nitro-2-sulfamoylbenzoate is a modified galactosylated drug that has been shown to inhibit the growth of cancer cells. Methyl 4-nitro-2-sulfamoylbenzoate binds to an enzyme called carbonic anhydrase, which is involved in the activation and deactivation of carbon dioxide. This drug inhibits the activity of this enzyme and prevents the conversion of carbon dioxide into bicarbonate ions, leading to a decrease in pH levels. Methyl 4-nitro-2-sulfamoylbenzoate also shows anticancer properties by inhibiting cyclin D1 and inducing apoptosis in cancer cells. The linker between the nitrobenzene group and methyl group is a triazole, which is synthesized using a chemical process that involves anhydride as a reagent.
Propiedades químicas
Consulta técnica sobre: 3D-CAA29701 Methyl 4-nitro-2-sulfamoylbenzoate
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
